This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Donald E. Slaughter: Inventor of Fibrinogen Receptor Antagonist Prodrugs
Introduction
Donald E. Slaughter is an inventor associated with Lansdale, Pennsylvania, and Merck & Co., Inc. His patent work concerns pharmaceutical prodrugs designed as fibrinogen receptor antagonists.
Latest Patents
Slaughter is credited with 1 patent: “Fibrinogen receptor antagonist prodrugs.” The patent describes fibrinogen receptor antagonist alcohol prodrugs, including compounds with the specified structural framework.
Career Highlights
His recorded patent is connected to Merck & Co., Inc., a pharmaceutical company. The available information identifies his contribution in the area of drug-related chemical inventions.
Collaborations
Slaughter’s listed coworkers include Laura A. Libby and Steven D. Young. Their names appear alongside his work on fibrinogen receptor antagonist prodrugs.
Conclusion
Donald E. Slaughter’s patent record highlights his contribution to pharmaceutical innovation through work on fibrinogen receptor antagonist prodrugs at Merck & Co., Inc.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile